Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

5.27
-0.2200-4.01%
Post-market: 5.270.00000.00%16:43 EDT
Volume:1.35M
Turnover:7.12M
Market Cap:101.93M
PE:-0.87
High:5.80
Open:5.80
Low:5.13
Close:5.49
52wk High:20.56
52wk Low:5.13
Shares:19.34M
Float Shares:13.25M
Volume Ratio:1.54
T/O Rate:10.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.00
PE(LYR):-0.89

Loading ...

Corbus Pharmaceuticals Holdings, - Expects to Initiate Phase 2 Monotherapy Study for Crb-913 in H1 2027

THOMSON REUTERS
·
Sep 14

Corbus Pharmaceuticals Announces Positive Topline Data from Canyon-1 Study of Daily Oral Crb-913 for the Treatment of Obesity

THOMSON REUTERS
·
Sep 14

Corbus Pharmaceuticals Holdings, - Crb-913 Treatment Discontinuations Due to Adverse Events Range from 3.1% to 13.1%

THOMSON REUTERS
·
Sep 14

Corbus Pharmaceuticals Holdings, - Crb-913 Achieves 5% Mean Weight Loss at 60 Mg After 12 Weeks

THOMSON REUTERS
·
Sep 14

Corbus Pharmaceuticals Holdings, - Crb-913 Well Tolerated with Favorable Psychiatric and Gi Adverse Event Profile

THOMSON REUTERS
·
Sep 14

Corbus Pharmaceuticals Holdings, - Crb-913 Data Support Potential for New Class of Oral Non-Incretin Obesity Medicines

THOMSON REUTERS
·
Sep 14

Stocks to Watch: Corbus Pharmaceuticals, Scholar Rock

Dow Jones
·
Sep 12

Corbus Pharmaceuticals Stock Surges Ahead of Drug Data Readout

Dow Jones
·
Sep 12

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 12

Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity

GlobeNewswire
·
Sep 12

Corbus Pharmaceuticals Holdings Inc. Stock Sheds 7.0%, Underperforms Peers

Dow Jones
·
Sep 11

Analysts Have Conflicting Sentiments on These Healthcare Companies: BioLife Solutions (BLFS) and Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Sep 09

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 03

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 02

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 28

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 25

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 21